Simonetta Viviani

2.7k total citations · 1 hit paper
56 papers, 1.8k citations indexed

About

Simonetta Viviani is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Simonetta Viviani has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 25 papers in Microbiology and 23 papers in Infectious Diseases. Recurrent topics in Simonetta Viviani's work include Bacterial Infections and Vaccines (25 papers), Pneumonia and Respiratory Infections (21 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Simonetta Viviani is often cited by papers focused on Bacterial Infections and Vaccines (25 papers), Pneumonia and Respiratory Infections (21 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Simonetta Viviani collaborates with scholars based in Italy, United States and France. Simonetta Viviani's co-authors include F. Marc LaForce, Chukiat Sirivichayakul, Marie‐Pierre Préziosi, Kriengsak Limkittikul, Pornthep Chanthavanich, Jean Lang, Mélanie Saville, Nadia Tornieporth, Arunee Sabchareon and Derek Wallace and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Simonetta Viviani

54 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

2012 636 citations Arunee Sabchareon, Derek Wallace et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simonetta Viviani Italy	19	821	770	725	474	183	56	1.8k
Laurent Coudeville France	24	734 0.9×	797 1.0×	999 1.4×	103 0.2×	171 0.9×	68	2.0k
Ana Marli Christovam Sartori Brazil	22	903 1.1×	383 0.5×	568 0.8×	110 0.2×	175 1.0×	81	1.4k
William Perea Switzerland	25	629 0.8×	656 0.9×	714 1.0×	221 0.5×	348 1.9×	42	1.7k
Betzana Zambrano Uruguay	19	295 0.4×	1.0k 1.4×	1.5k 2.0×	190 0.4×	78 0.4×	43	1.9k
Birgitte Giersing Switzerland	25	636 0.8×	700 0.9×	502 0.7×	205 0.4×	269 1.5×	77	2.0k
Kee Tai Goh Singapore	23	792 1.0×	924 1.2×	531 0.7×	83 0.2×	116 0.6×	53	2.2k
Piero Luigi Lai Italy	20	712 0.9×	319 0.4×	156 0.2×	127 0.3×	196 1.1×	65	1.2k
Terapong Tantawichien Thailand	20	527 0.6×	437 0.6×	411 0.6×	157 0.3×	74 0.4×	74	1.2k
Lars Rombo Sweden	23	615 0.7×	426 0.6×	455 0.6×	46 0.1×	110 0.6×	47	1.4k
Shelly Bolotin Canada	22	1.0k 1.2×	549 0.7×	135 0.2×	256 0.5×	372 2.0×	70	1.6k

Countries citing papers authored by Simonetta Viviani

Since Specialization

Citations

This map shows the geographic impact of Simonetta Viviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Viviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Viviani more than expected).

Fields of papers citing papers by Simonetta Viviani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simonetta Viviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Viviani. The network helps show where Simonetta Viviani may publish in the future.

Co-authorship network of co-authors of Simonetta Viviani

This figure shows the co-authorship network connecting the top 25 collaborators of Simonetta Viviani. A scholar is included among the top collaborators of Simonetta Viviani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simonetta Viviani. Simonetta Viviani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marchi, Serena, Gianvito Lanave, Michele Camero, et al.. (2022). SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy. Viruses. 14(7). 1441–1441. 1 indexed citations

Marchi, Serena, Filippo Dragoni, Adele Boccuto, et al.. (2022). Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage. Acta Tropica. 237. 106736–106736. 1 indexed citations

Trombetta, Claudia Maria, Serena Marchi, Simonetta Viviani, et al.. (2021). Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients. Viruses. 13(7). 1347–1347. 11 indexed citations

Marchi, Serena, Simonetta Viviani, Edmond J. Remarque, et al.. (2021). Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS ONE. 16(7). e0253977–e0253977. 23 indexed citations

Marchi, Serena, Edmond J. Remarque, Simonetta Viviani, et al.. (2021). Measles immunity over two decades in two large Italian Regions: How far is the elimination goal?. Vaccine. 39(40). 5928–5933. 2 indexed citations

Pitisuttithum, Punnee, Jittima Dhitavat, Chukiat Sirivichayakul, et al.. (2021). Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines. EClinicalMedicine. 37. 100976–100976. 18 indexed citations

Trombetta, Claudia Maria, Simonetta Viviani, Emanuele Montomoli, & Serena Marchi. (2020). Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy). PubMed. 62(2). E372–E376. 6 indexed citations

Marchi, Serena, et al.. (2019). Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy. BMJ Open. 9(10). e032987–e032987. 4 indexed citations

LaForce, F. Marc, Mamoudou Harouna Djingarey, Simonetta Viviani, & Marie‐Pierre Préziosi. (2017). Lessons from the Meningitis Vaccine Project. Viral Immunology. 31(2). 109–113. 8 indexed citations

10.

Enwere, Godwin, Prasad S. Kulkarni, Katharina Hartmann, et al.. (2015). Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons. Clinical Infectious Diseases. 61(suppl_5). S501–S506. 2 indexed citations

11.

Diomandé, Fabien, Kirsten Vannice, Marie‐Pierre Préziosi, et al.. (2015). Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013. Clinical Infectious Diseases. 61(suppl_5). S459–S466. 14 indexed citations

12.

Idoko, Olubukola T., S.N. Okolo, Brian D. Plikaytis, et al.. (2014). The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines. Vaccine. 32(33). 4220–4227. 12 indexed citations

13.

Sabchareon, Arunee, Derek Wallace, Chukiat Sirivichayakul, et al.. (2012). Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet. 380(9853). 1559–1567. 636 indexed citations breakdown →

14.

LaForce, F. Marc, Neil Ravenscroft, Mamoudou Harouna Djingarey, & Simonetta Viviani. (2009). Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution. Vaccine. 27. B13–B19. 100 indexed citations

15.

Plymoth, Amelie, Simonetta Viviani, & Pierre Hainaut. (2009). Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention. Cancer Letters. 286(1). 15–21. 43 indexed citations

16.

Kanra, G, et al.. (2006). Safety and Immunogenicity of a New Fully Liquid DTPw-HepB-Hib Combination Vaccine in Infants. Human Vaccines. 2(4). 155–160. 27 indexed citations

17.

Tamm, Eda, et al.. (2004). Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem™) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate. Vaccine. 23(14). 1715–1719. 13 indexed citations

18.

Viviani, Simonetta, et al.. (2003). Immunogenicity and safety in infants of a DTwPHib full liquid vaccine. Acta Paediatrica. 92(5). 541–545. 1 indexed citations

19.

Viviani, Simonetta, Andrew Jack, A. J. Hall, et al.. (1999). Hepatitis B vaccination in infancy in The Gambia: protection. Vaccine. 17(23-24). 2946–2950. 120 indexed citations

20.

Binkin, Nancy, Patrizia Carrieri, G Salamina, et al.. (1994). Childhood Vaccination Coverage in Italy: Results of a Seven-Region Survey. Bulletin of the World Health Organization. 72(6). 885–895. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact